Official-source directory
Conference Papers
13,885
available papers
10
available conferences
Papers
Showing 5301–5320 of 13,885
PharmaSUG2021paper·US·Data Standards
Adding Rows to a BDS Dataset: When to Use DTYPE in Addition to Metadata DS-081
PharmaSUG2021paper·US·Data Standards
Untangling the Knot – Implementing Analysis Results Standards (Using SAS) DS-130
PharmaSUG2021paper·US·Data Standards
Biomedical Concepts – An Emerging CDISC Data Standard: A Stepwise Approach for Building a Library of Data Definitions DS-142
PharmaSUG2021paper·US·Data Standards
Validation of CDISC specifications using VALSPEC utility macro DS-165
PharmaSUG2021paper·China·Data Standards/CDISC and Regulatory Submission
A Customizable Conformance Check Tool Design DS-007 Shanghai
PharmaSUG2021paper·China·Data Standards/CDISC and Regulatory Submission
SAS Macro Solution for NMPA Submission Data Validation Rules DS-009 Shanghai
PharmaSUG2021paper·China·Data Standards/CDISC and Regulatory Submission
Consideration and Solutions of Garbled Codes in Multiple Languages Projects DS-033 Shanghai
PharmaSUG2021paper·China·Data Standards/CDISC and Regulatory Submission
SDTM Annotated CRF Digitalization DS-036 Shanghai
PharmaSUG2021paper·China·Data Standards/CDISC and Regulatory Submission
Annotated CRF Submission to NMPA for Foreign Database DS-046 Shanghai
PharmaSUG2021paper·China·Data Standards/CDISC and Regulatory Submission
Challenges and solutions for e-data submission to NMPA under new regulation DS-047 Shanghai
PharmaSUG2021paper·China·Data Standards/CDISC and Regulatory Submission
Coding Data Translation Automation DS-051 Shanghai
PharmaSUG2021paper·China·Data Standards/CDISC and Regulatory Submission
How to present exposure data nicely in the SDTM? DS-083 Shanghai
PharmaSUG2021paper·China·Data Standards/CDISC and Regulatory Submission
A case of mistaken ID: reimagining rescreenings and reenrollments DS-102 Shanghai
PharmaSUG2021paper·China·Data Validation & Management (DM)
Quality Management of Critical Data from eDevice in Decentralized Clinical Trial DM-016 Shanghai
PharmaSUG2021paper·China·Data Validation & Management (DM)
Don’t Panic: A Data Manager’s Guide to SDTM DM-018 Shanghai
PharmaSUG2021paper·China·Data Validation & Management (DM)
Implementation of Data Cut-Off in Analysis of Oncology Clinical Trials DM-023 Shanghai
PharmaSUG2021paper·China·Data Visualization and Graphics
Review Response Data with an R Shiny App DV-005 Shanghai
PharmaSUG2021paper·China·Data Visualization and Graphics
SAS Macro to Derive Integrated PET+CT Response in FDG-avid Lymphoma per Lugano 2014 DV-022 Shanghai